[Improvement in anti-hemophilic preparations and its problems. 6. Function analysis of human plasma proteins passed through the microporous regenerated cellulose membrane (BMM) hollow fiber]. 1988

K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro

UI MeSH Term Description Entries
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D005374 Filtration A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Filtrations
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
January 1994, Archives of virology,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
January 1990, Transfusion science,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
September 2013, Journal of hazardous materials,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
April 1986, Applied and environmental microbiology,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
January 1989, Nihon rinsho. Japanese journal of clinical medicine,
K Okuyama, and Y Fukushima, and Y Miura, and R Honma, and S Manabe, and G Ishikawa, and M Satani, and K Komuro
August 1991, The Journal of general virology,
Copied contents to your clipboard!